The Status and Future of the Shift to Non Personal Promotion in Pharma Marketing
It’s been a year since the onset of COVID-19 upended the way we live our lives and conduct our business. It’s now clear that non-personal promotion (NPP) with providers has cemented a larger role in the pharma marketing mix – regardless of whether we’re able to regain a semblance of pre-COVID interaction in 2021.
As pharma continues to grapple with reduced airtime with physicians, NPP commands a more significant share of 2021 marketing budgets, and organizations search for ways to connect in a wholly virtual world. Opportunities to innovate abound.
In this roundtable, we’ll discuss what we’re hearing about practical methods that pharma is using to balance personal and non-personal promotion, as well as the importance of interconnectivity across virtual digital platforms.
In under just 60 minutes you'll learn:
The biggest challenges pharma faced in 2020 while shifting to a virtual mindset—and what challenges will persist in 2021
How changing patient populations and personalized care impact customer engagement models
How existing digital technologies support new customer engagement model